Earnings History Data for Kyverna Therapeutics, Inc. (KYTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Kyverna Therapeutics, Inc.
Kyverna Therapeutics Inc. is a patient-centered clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company's lead product candidate includes KYV-101. Kyverna Therapeutics Inc. is based in EMERYVILLE, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2024 | AH | KYTX | Kyverna Therapeutics, Inc. | 239.00 | -0.80 | -0.77 | 0.00 | Kyverna Therapeutics GAAP EPS of -$0.80 [11/14/2024 12:30 PM] |
4.83 | -0.23 (-4.55%) |
5.16 | 0.10 (1.98%) |
4.40 - 35.06 | 219,230 | 250,000 | 2,950 | ||
|
||||||||||||||||||
| 12-08-2024 | AH | KYTX | Kyverna Therapeutics, Inc. | 294.00 | -0.67 | -0.70 | 0.00 | Kyverna Therapeutics GAAP EPS of -$0.67 [8/13/2024 10:58 AM] |
6.99 | 0.46 (7.04%) |
6.72 | 0.19 (2.91%) |
6.30 - 35.06 | 515,421 | 500,000 | 12,049 | ||
| 14-05-2024 | PM | KYTX | Kyverna Therapeutics, Inc. | 604.00 | -1.12 | -0.88 | 0.00 | Kyverna Therapeutics reports Q1 GAAP EPS of -$1.12 [5/15/2024 9:10 AM] |
15.86 | 0.36 (2.32%) |
15.80 | 0.30 (1.94%) |
12.26 - 35.06 | 462,358 | 400,000 | 4,880 | ||